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Among human rickettsial diseases caused by micro-organisms of the genus Rickettsia (Order 
Rickettsiales; Family Rickettsiaceae), transmitted to human hosts through arthropod vectors, 
Mediterranean Spotted Fever, or Boutonneuse Fever, and Rocky Mountain Spotted Fever are considered 
to be important infectious diseases due to continued prevalence in the developed world, difficulties in 
early and accurate diagnosis, and potentially fatal outcome in severe cases. Proliferation of rickettsiae, 
at the site of the tick bite, results in focal epidermal and dermal necrosis (tache noire). Rickettsiae then 
spread via lymphatic vessels to the regional lymph nodes, and, via the bloodstream, to skin, brain, 
lungs, heart, liver, spleen and kidneys. The pathogen invades and proliferates in the endothelial cells of 
small vessels, target cells of rickettsial infection, together, destroying them, and spreading the infection 
to the endothelia of the vascular tree. The damage of the endothelium, and the subsequent endothelia 
dysfunction, is followed by the activation of acute phase responses, with alteration in the coagulation 
and in the cytokine network, together with a transient immune dysregulation, characterized by the 
reduction in peripheral CD4+ T lymphocytes. 
The human rickettsial diseases are a variety 
of clinical entities caused by micro-organisms 
of the genus Rickettsia (Order Rickettsiales; 
Family Rickettsiaceae). The pathogen invades and 
proliferates in the endothelial cells (ECs) of small 
vessels, target cells of rickettsial infection, destroying 
them, and spreading the infection to the endothelia 
of the vascular tree. The damage of the endothelium, 
and the subsequent endothelia dysfunction, is 
followed by the activation of acute phase responses, 
with alteration in the coagulation and in the 
cytokine network, together with a transient immune 
dysregulation, characterized by the reduction in 
peripheral CD4+ T lymphocytes. The mechanisms 
of host defence are not yet completely understood, 
although cell-mediated immunity is believed to play 
a crucial role (1). 
ENDOTHELIAL CELL INVASION AND INJURY
Vasculitis of small vessels of numerous 
organs (including central nervous system, lung, 
myocardium, liver, and kidney) is a typical 
event during Boutonneuse Fever (BF), as 
seen by histopathologic examination, and the 
complications are attributed to changes in vascular 
permeability and oedema due to endothelial injury 
(2). 
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EC invasion
Although some signalling events involved in 
rickettsial entry into the ECs have been documented 
(i.e. activation of Src-family tyrosine kinases, 
tyrosine phosphorylation of focal adhesion kinase, 
and β1-integrin activation), host proteins mediating 
entry are not known (2). 
In some studies it has been reported that Ku70 
subunit of DNA-dependent protein kinase is a 
receptor involved in R. conorii internalization (Fig. 
1). Ku70 is recruited to R. conorii entry sites, and 
inhibition of Ku70 expression impairs R. conorii 
internalization. R. conorii infection also stimulates 
the ubiquitination of Ku70. In addition, an ubiquitin 
ligase, called c-Cbl, is recruited to R. conorii entry 
foci, and downregulation of c-Cbl blocks rickettsial 
invasion and Ku70 ubiquitination (3). 
Experimental approaches have identified the 
rickettsial outer membrane protein B (OmpB) as 
a ligand for Ku70. Antibodies against OmpA and 
OmpB are able to protect against reinfection, but 
they do not play a key role in immunity against 
primary infection (4). 
The rickettsiae induce internalization by 
phagocytosis, associated with phospholipase 
A
2
 activity, apparently of rickettsial origin, and 
escaping from the phagosome into the cytosol by an 
unidentified mechanism, even if some experimental 
data suggest a role for the tlyC and pld genes, with 
potential membranolytic activities, in the process 
of phagosomal escape by R. prowazekii (5). In the 
cytosol, R. conorii stimulates the polymerization 
of host cell F-actin, controlled by the Arp2/3 
complex, using the bacterial surface RickA protein, 
which propels the bacterium through the cytoplasm 
and across the cell membrane into the adjacent 
endothelial cell or extracellular space (Fig. 1) (6). 
EC injury
The infection of cultured ECs causes the 
induction of oxidative stress mechanisms, as 
evidenced by accumulation of reactive oxygen 
species (ROS), induced by the combination of tumor 
necrosis factor-alpha (TNF-α) and interferon-gamma 
(IFN-γ) production (7), altered levels of antioxidant 
enzymes, and depleted levels of intracellular reduced 
thiols, together with alterations in the levels of 
mRNA expression of selected antioxidant enzymes 
in in vivo experimental infection (8) (Fig. 2). 
Production of cytokines and chemokines by ECs
Human umbilical vein endothelial cells 
(HUVECs), infected by R. conorii, actively secrete 
large amounts of IL-8 and IL-6, via an IL-1α 
dependent pathway (Fig. 3) (9). 
IL-1α, produced by HUVECs, is mainly in a 
precursor form. Therefore, IL-1α precursor can be 
secreted and immediately bound to the type I IL-1 
receptor (10). Alternatively, IL-1α can be active 
without being secreted and fixed on endothelial 
surface membranes in cell-cell membrane 
interaction. Thus, IL-1α can act as an autocrine 
factor on HUVECs. IL-1α activates ECs, and 
increases the expression of adhesion molecules on 
both ECs and leukocytes by inducing the production 
of other cytokines, such as IL-8 and IL-6 (10). 
IL-8 and IL-6 might play a role in the development 
of vasculitis induced by rickettsial infection. IL-8 is 
a potent chemotactic agent for polymorphonuclear 
leukocytes, stimulates polymorphonuclear 
leukocyte transendothelial migration, and activates 
their functions, but it seems to have no effect on 
endothelial cells (11). IL-6, also secreted by R. 
conorii-infected HUVECs, may mediate the acute 
phase protein production associated with BF. IL-6 
might also be implicated in the local differentiation 
and proliferation of T lymphocytes, through its 
stimulatory effects on IL-2 production and IL-2 
receptor (IL-2R) expression in T cells, and in B 
lymphocyte stimulation (12).
In addition, the expression of the chemokines 
CXCL9 and CXCL10, known to target CD8+ and 
CD4+ T lymphocytes, is significantly high in ECs of 
C3H/HeN mice infected with R. conorii. The peak 
of expression of these chemokines occurred 4 days 
before CD8+ T cells infiltrated the infected tissues. 
Therefore, CXCL9 and CXCL10 may play a role 
early during the immune response against rickettsial 
infections (13). Similarly, the peak of expression 
of fractalkine (CX3CL1), another chemokine 
expressed mainly by endothelial cells, on day 3 of 
infection, coincided with the time of infiltration of 
macrophages into infected tissues and preceded the 
peak of rickettsial content in tissues (14).
Induction of cellular adhesion molecules
In vitro R. conorii infection of ECs, through the 
P. MANSUETO ET AL.
132 133Journal of Biological Regulators & Homeostatic Agents
release of the early response cytokines (IL-1α, IL-6, 
and TNF-α) and other components of the acute phase 
reaction, enhances the expression on the surface of 
ECs and polymorphonuclear leukocytes of cellular 
adhesion molecules (CAM), i.e. E-selectin, VCAM-
1, and ICAM-1, which are responsible for enhanced 
rolling and the adherence of mononuclear cells to 
infected ECs (Fig. 3) (15). 
In addition, during the acute phase of BF, soluble 
forms of these adhesion molecules (sL-selectin, 
sE-selectin, s-VCAM-1, and sICAM-1) are shed 
into the plasma by the proteolytic cleavage of 
their membrane-bound counterparts from activated 
leukocytes and ECs, and/or by the differential 
splicing of their mRNA (Fig. 3). The shed forms 
are functionally active and could be involved in the 
control of adhesive interactions between the cells. 
The persistence of high levels of this CAM has 
negative prognostic value, and could be useful to 
monitor disease evolution (15). 
Platelet activation 
In the acute phase of BF, through measurements of 
a major metabolite of thromboxane (TX) in the urine 
(11-dehydro-TXB
2
), a marker of platelet activation, 
and of plasma prothrombin fragment 1+2, whose 
levels reflect activation of prothrombin to thrombin, 
biochemical evidence has been demonstrated 
for the occurrence of a TXA
2
-dependent platelet 
activation and thrombin generation in vivo. These 
phenomena could, at least in part, account for 
clinical manifestations of BF, such as vasculitis and 
focal microthrombus formation (16). 
Mechanism of intracellular killing of R. conorii
Perivascular infiltrations of CD4+ and CD8 T 
lymphocytes, macrophages, natural killer (NK) cells, 
infected ECs themselves, and marginated elements 
of blood secrete cytokines and chemokines that 
activate infected ECs, by paracrine and autocrine 
stimulation, to kill intracellular rickettsiae. Human 
cells might be capable of controlling rickettsial 
infections intracellularly, the most relevant location 
in these infections, by a cytokine- and chemokine-
dependent, nitric oxide-dependent mechanism, and, 
in particular, by one or a combination of these three 
Fig. 1. Endothelial cell invasion.
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mechanisms involving: 1) nitric oxide synthesis; 
2) hydrogen peroxide production; 3) tryptophan 
degradation, resulting in its intracellular depletion 
and starvation for the parasite (17).
ACUTE PHASE RESPONSE
In BF, the invasion and proliferation of rickettsiae 
in the ECs is the early event responsible for acute 
phase response activation. Some acute phase 
responses appear to be involved in the promotion 
of inflammatory events (IL-1α, IL-8, IFN-γ, 
complement proteins, and fibrinogen), while others 
appear to moderate them (ceruloplasmin, and α
1
-
antitrypsin). After the resolution of the infection, 
all mediators reach the normal range, acute phase 
response subsides, and the homeostatic balance is 
restored (Fig. 4) (18).   
The analysis of cytokine serum levels indicates 
that IL-1α is not detectable in the blood of acute 
BF patients, which probably depends on the fact 
that stimulation in ECs causes the production of 
IL-1α predominantly in cell-associated form, thus 
contributing to the localized procoagulant and 
inflammatory responses which occur in the course of 
rickettsial disease. The undetectable serum levels of 
IL-8 may be due to its prevalent concentrations on 
endothelial protrusions, either in vesicles or on the 
plasma membrane (18).   
As for as IFN-γ, its increase has been detected 
in the firsts week, followed by its normalization. 
Furthermore, IFN-γ appears to be associated with 
complement protein modifications. In fact, IFN-γ 
is the main inducer of C4 gene expression (18-19). 
Complement could prove useful for the elimination 
of infected, damaged or compromised cells, exerting 
anti-inflammatory activities (18).   
The detection of high levels of serum fibrinogen, 
in the first week of BF infection, constitutes 
the primary event inducing a local activation of 
haemostasis, through platelet activation, and it is a 
cursory indicator of inflammation in most human 
infections (18).   
Also anti-inflammatory mediators (i.e. 
ceruloplasmin and α
1
-antitrypsin) are detected 
in patients affected by BF. The strong release 
Fig. 2. Endothelial cell injury.
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of ceruloplasmin might minimize the level of 
inflammatory response, acting as scavenger 
of oxygen free radicals, or ROS, produced by 
leukocytes (18).  α
1
-antitrypsin persists at high levels 
in BF patients until the third week and could indicate 
that this proteinase inhibitor is required for a long 
period, both to neutralize the lysosomal hydrolases 
released following the infiltration of macrophages 
and, more importantly, to induce the release of anti-
inflammatory cytokines (18).   
TOLL-LIKE RECEPTORS AND THE INNATE 
IMMUNE SYSTEM
One of the mechanisms by which the innate 
immune system senses the invasion of pathogenic 
microrganisms is through the pattern recognition 
receptors (PRRs), which are germ line-encoded 
receptors, including transmembrane Toll-like 
receptors (TLRs), that can sense pathogen-
associated molecular patterns, and initiate signalling 
cascades that lead to an innate immune response. 
The Toll-like receptor 4 (TLR4) plays an important 
role in inflammation and immunity. It has been 
demonstrated that the +869G single-nucleotide 
polymorphism of the TLR4 gene, known to 
attenuate receptor signalling, decrease endotoxin 
responsiveness and determine poor outcome 
from sepsis, is overexpressed in BF patients, with 
significant differences, in the frequency of TLR 
genotypes and alleles, compared with age-matched 
controls. These data might be interpreted as one of 
the hypothetical bases for a genetic predisposition 
to BF (20). 
IMMUNOLOGIC ALTERATIONS
Rickettsial-dendritic cell interaction
The role played by dendritic cells (DCs), known 
as specialized antigen presenting cells, initiators 
and orchestrators of the immune response, remains 
unclear in rickettsial infections. It seems that 
a vigorous proinflammatory response of DCs, 
associated with up-regulation of CD40, CD80, 
CD86, and major histocompatibility complex 
class II, production of IL-2, IL-12, and IL-23, and 
Fig. 3. Production of cytokines by ECs and induction of cellular adhesion molecules.
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mediated by the increase in T
H
1-type (TNF-α and 
IFN-γ), and in T
H
2-type cytokines (IL-10, and IL-
6), appear to be important for the healing process 
(Fig. 5). In detail, TNF-α, IFN-γ, IL-10, and IL-6 are 
significantly increased in the blood of patients with 
acute BF compared with those detected from control 
healthy subjects (22). 
In addition to the above, also in mild/moderate 
Mountain Spotted Fever (MSF) a strong and 
balanced intralesional proinflammatory and anti-
inflammatory response is demonstrable, with a 
dominant type 1 immunity, whereas severe MSF is 
associated with increased expression of chemokine, 
i.e. RANTES, mRNA (23). 
The dramatic increase in TNF-α, detected in the 
first week after the onset of symptoms, together with 
IFN-γ, is one of the early events observed in acute 
BF patients, followed by the increase of IL-10 and 
IL-6 (Fig. 5) (22). Activated antigen presenting cells 
(i.e. activated macrophages) produce high levels 
of TNF-α. TNF-α induces IFN-γ production from 
activated CD4+ T cells and NK cells. One important 
production of antigen-specific IFN-γ in CD4+ T 
cells, is involved in the appearance of a protective 
immunity to rickettsiae (21).
Analysis of lymphocyte subpopulations
In acute BF patients there is a reduction of 
circulating T cells and, in particular, of CD4+ 
(helper/inducer T cells), CD4+/CD45RO+ (memory 
T cells), and CD4+/CD45+ (naive T cells) subsets. 
These modifications may be due to the cell adhesion 
to vascular endothelium, followed by their entrance 
into the sites of inflammation. Also apoptosis, 
spontaneous and activation-induced, could have a 
role in this decrease. The other lymphocytic subsets 
(CD8+ [suppressor/cytotoxic T cells], CD16+ 
[NK cells], and CD20+ [B cells]) tend to decrease 
in a non-significant way, whereas monocytes/
macrophages (CD14+/HLA-DR+) are significantly 
increased. All cell subsets return to the normal levels 
after successful treatment, except for monocytes, 
that are persistently high after recovery (22). 
The inflammatory and immunologic responses, 
Fig. 4. Acute phase response. 
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effect of IFN-γ on macrophages is the induction of 
receptors for TNF-α, so that the binding of TNF-α 
on macrophages might further activate these cells by 
an autocrine TNF-α loop, thus increasing their anti-
rickettsial activity, via the induction of NO synthesis 
and incretion (24). Moreover, the persistence of high 
serum levels of TNF-α, in recovered patients, could 
be a sign of residual local lesions. A relationship has 
also been observed between serum TNF-α and a high 
production of one the two soluble TNF receptors, 
sTNF-RI; persisting high values of sTNF-RI, in BF, 
could be indicator of disease activity (25).
Because IL-10 (a T
H
2-type cytokine) suppresses 
the ability of IFN-γ-activated macrophages to 
produce inflammatory mediators, the persistence of 
high levels of IL-10 could be due to its ability to 
down-regulate the potential tissue-damaging effects, 
mediated by the increase in T
H
1-type cytokines (26). 
The profile of serum IL-6 (another T
H
2-type 
cytokine) production, in patients with acute BF and 
after recovery, is similar to that of IL-10. In acute BF, 
IL-6 could acts as an anti-inflammatory cytokine, 
rather than as a growth and differentiation factor for 
B cell and immunoglobulin production (27). 
Therefore, in BF patients, T
H
1- and T
H
2-type 
responses are not characteristically polarised, as 
both activating (i.e. TNF-α, IFN-γ) and suppressive 
(i.e. IL-10 and IL-6) cytokines are increased. In 
BF, as in any other inflammatory environment, 
counterbalancing mechanisms are normally 
produced to curtail the process, thus IL-10 and IL-
6 could be capable of derailing T
H
1-type responses 
and deactivating macrophages, thereby, moderating 
tissue injury (28).
Finally, in BF patients, IL-12, predominantly 
produced by monocytes, appears to act very early, 
favouring T
H
1 differentiation and T
H
1-type cytokine 
production, primarily of  IFN-γ from T cells and 
NK, acting as a growth factor for activated T cells 
and NK, enhancing cytotoxic activity of NK, and 
contributing to the phagocyte cell activation and the 
innate resistance to intracellular pathogens (29). 
ROLE OF CD8+ T CELLS
CD8+ T lymphocytes contribute to 
Fig. 5. Immunologic alterations.
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protective immunity to rickettsiae by both Major 
Histocompatibility Complex (MHC)-I-restricted 
Cytotoxic T-lymphocyte (CTL) activity and 
production of IFN-γ. However, CTL activity may 
be more critical for the recovery from rickettsial 
infection than the effects of IFN-γ production (Fig. 
5) (30). 
Infected cells are eliminated by apoptosis 
associated with CTL activity. Although apoptotic 
loss of endothelium could be considered a pathologic 
event, it favours the host, more than the survival or 
the necrosis of an infected cell. Survival of infected 
ECs would permit further growth of the rickettsiae, 
while necrosis would release rickettsiae, allowing 
their spread to establish foci of infection in other 
cells. In contrast, rickettsiae-containing apoptotic 
bodies would be phagocytised rapidly and digested 
intracellularly (30). 
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